Back to Newsroom

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in December 2015

NORWOOD, MA — (Marketwired) — 11/23/15 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at two upcoming investor conferences in December.

Click here to read more